We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current THRD market cap is 538.03M. The company's latest EPS is USD -0.7637 and P/E is -17.52.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.99M | -10.71M | -10.85M | -10.41M | -11.29M |
| Net Income | -9.09M | -7.56M | -7.34M | -6.84M | -7.86M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -11.12M | -19M | -37.71M | -43.95M |
| Net Income | -12.81M | -29.61M | -35.16M | -30.82M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 291.39M | 285.82M | 282.25M | 277.71M | 270.52M |
| Total Liabilities | 8.72M | 7.81M | 9.29M | 8.63M | 7.02M |
| Total Equity | 282.67M | 278.01M | 272.96M | 269.09M | 263.5M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.43M | 129.16M | 298.68M | 277.71M |
| Total Liabilities | 8.09M | 5.69M | 9.61M | 8.63M |
| Total Equity | -18.36M | -46.71M | 289.07M | 269.09M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -6.68M | -10.64M | -14.82M | -20.43M | -6.29M |
| Investing | N/A | -168k | -168k | -169k | N/A |
| Financing | N/A | 58k | 1,000 | 799k | 49k |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.19M | -15.75M | -34.92M | -20.43M |
| Investing | N/A | N/A | -36k | -169k |
| Financing | 10.83M | 135.75M | 195.99M | 799k |
| Market Cap | 538.03M |
| Price to Earnings Ratio | -17.52 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.01 |
| Price to Book Ratio | 2.01 |
| Dividend Yield | - |
| Shares Outstanding | 40.36M |
| Average Volume (1 week) | 76.62k |
| Average Volume (1 Month) | 89.48k |
| 52 Week Change | 161.37% |
| 52 Week High | 16.94 |
| 52 Week Low | 4.7249 |
| Spread (Intraday) | 7.22 (48.42%) |
| Company Name | Third Harmonic Bio Inc |
| Address |
300 technology square cambridge, massachusetts 02139 |
| Website | https://www.thirdharmonicbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
